EBS Financials
Emergent Biosolutions Inc - Financial statements & key metrics
Stock Price
$6.22
Market Cap
$416.38M
P/E Ratio
9.4
EPS
$1.32
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$1.04B
Gross Profit
-
Operating Income
-
Net Income
$-190.60M
EPS (Diluted)
$-3.60
Balance Sheet Highlights
Total Assets
$1.39B
Total Liabilities
$906.90M
Shareholders Equity
-
Cash & Equivalents
$99.50M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$58.70M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
37.8%
Net Margin
9.6%
ROE
13.9%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is EBS revenue?
EBS's most recent quarterly revenue was $1.04B. Annual revenue can be calculated by summing the four most recent quarters.
Is EBS profitable?
EBS reported a loss of $190.60M in the most recent quarter. The net profit margin is 9.6%.
What is EBS market cap?
EBS has a market capitalization of $416.38M, making it a small-cap stock.
Does EBS have debt?
View EBS's balance sheet for debt information.
What is EBS cash flow?
Cash flow data is available in the full financial statements.